Jasper Dingemanse

Title: The Innovative Contributions of Jasper Dingemanse

Introduction

Jasper Dingemanse is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work focuses on innovative dosing regimens and crystalline forms of various compounds, showcasing his expertise in medicinal chemistry.

Latest Patents

One of his latest patents is titled "Dosing regimen for a selective S1P1 receptor agonist." This invention relates to a specific dosing regimen for the compound (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[Z]ylidene]-2-([Z]-propylimmo)-3-o-tolyl-thiazolidin-4-one. Another significant patent is for the "Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol," which pertains to a crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol.

Career Highlights

Throughout his career, Jasper has worked with prominent companies in the pharmaceutical industry, including Actelion Pharmaceuticals Ltd and Idorsia Pharmaceuticals Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development.

Collaborations

Jasper has collaborated with several talented individuals in his field, including Andreas Krause and Matthias Hoch. These collaborations have further enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Jasper Dingemanse's contributions to the pharmaceutical industry through his patents and collaborations highlight his innovative spirit and dedication to advancing medicinal chemistry. His work continues to impact the field positively, paving the way for future developments.